Megakaryocytic differentiation in human chronic myelogenous leukemia K562 cells induced by ionizing radiation in combination with phorbol 12-myristate 13-acetate

Journal of Radiation Research

Volumn 54, Issue 3, 2013, Pages 438-446

  Hirose, Katsumi ^a   Monzen, Satoru ^a   Sato, Haruka ^a   Sato, Mariko ^a   Aoki, Masahiko ^a   Hatayama, Yoshiomi ^a   Kawaguchi, Hideo ^a   Narita, Yuichiro ^a   Takai, Yoshihiro ^a   Kashiwakura, Ikuo ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

K562 cells; MAPK; Megakaryocytopoiesis; ROS

Indexed keywords

CELL CULTURE; DISEASES; ENZYME ACTIVITY; GENE EXPRESSION; RADIATION SHIELDING;

CHRONIC MYELOGENOUS LEUKEMIA; INDUCTION THERAPY; K562 CELLS; LEUKAEMIA CELLS; MEGAKARYOCYTIC DIFFERENTIATIONS; MEGAKARYOCYTOPOIESIS; MITOGEN-ACTIVATED PROTEIN KINASE; PHORBOL 12 MYRISTATE 13 ACETATES; PROTEIN KINASE PATHWAYS; REACTIVE OXYGEN SPECIES;

IONIZING RADIATION;

EID: 84877746279     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrs125     Document Type: Article

References (26)

1. Rowley JD. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973;243:290-3.
2. Nowell PC, Hungerford DA. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 1960;25:85-109.
3. Melo JV, Barnes DJ. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 2007;7:441-53.
4. Gorre ME, Mohammed M, Ellwood K et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001;293:876-80.
5. Hait WN, Choudhury S, Srimatkandada S et al. Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents. J Clin Invest 1993;91: 2207-15.
6. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 2008;295:C849-68.
7. Sawa T, Arimoto H, Akaike T. Regulation of redox signaling involving chemical conjugation of protein thiols by nitric oxide and electrophiles. Bioconjug Chem 2010;21:1121-9.
8. Zhu QS, Xia L, Mills GB et al. G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth. Blood 2006;107:1847-56.
9. Buggisch M, Ateghang B, Ruhe C et al. Stimulation of ES-cell-derived cardiomyogenesis and neonatal cardiac cell proliferation by reactive oxygen species and NADPH oxidase. J Cell Sci 2007;120:885-94.
10. Sardina JL, Lopez-Ruano G, Sanchez-Abarca LI et al. p22phox-dependent NADPH oxidase activity is required for megakaryocytic differentiation. Cell Death Differ 2010;17: 1842-54.
11. Bertram C, Hass R. Cellular responses to reactive oxygen species-induced DNA damage and aging. Biol Chem 2008;389:211-20.
12. Quintiliani M. The oxygen effect in radiation inactivation of DNA and enzymes. Int J Radiat Biol Relat Stud Phys Chem Med 1986;50:573-94.
13. Mikkelsen RB, Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 2003;22:5734-54.
14. von Wangenheim KH, Peterson HP. Control of cell proliferation by progress in differentiation: clues to mechanisms of aging, cancer causation and therapy. J Theor Biol 1998;193: 663-78.
15. Herrera R, Hubbell S, Decker S et al. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells. Exp Cell Res 1998;238:407-14.
16. Rouyez MC, Boucheron C, Gisselbrecht S et al. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Mol Cell Biol 1997;17:4991-5000.
17. Whalen AM, Galasinski SC, Shapiro PS et al. Megakaryocytic differentiation induced by constitutive activation of mitogenactivated protein kinase kinase. Mol Cell Biol 1997;17: 1947-58.
18. Melemed AS, Ryder JW, Vik TA. Activation of the mitogenactivated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells. Blood 1997;90:3462-70.
19. Colamonici OR, Trepel JB, Neckers LM. Phorbol ester enhances deoxynucleoside incorporation while inhibiting proliferation of K-562 cells. Cytometry 1985;6:591-6.
20. Conde I, Pabon D, Jayo A et al. Involvement of ERK1/2, p38 and PI3K in megakaryocytic differentiation of K562 cells. Eur J Haematol 2010;84:430-40.
21. Caja L, Sancho P, Bertran E et al. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-β-induced cell death through impairing up-regulation of the NADPH oxidase NOX4. Cancer Res 2009;69:7595-602.
22. Ramiro-Cortes Y, Guemez-Gamboa A, Moran J. Reactive oxygen species participate in the p38-mediated apoptosis induced by potassium deprivation and staurosporine in cerebellar granule neurons. Int J Biochem Cell Biol 2011;43: 1373-82.
23. Jacquel A, Herrant M, Defamie V et al. A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis. Oncogene 2006;25:781-94.
24. Shelly C, Petruzzelli L, Herrera R. PMA-induced phenotypic changes in K562 cells: MAPK-dependent and -independent events. Leukemia 1998;12:1951-61.
25. Monzen S, Tashiro E, Kashiwakura I. Megakaryocytopoiesis and thrombopoiesis in hematopoietic stem cells exposed to ionizing radiation. Radiat Res 2011;176:716-24.
26. Kato K, Takahashi K, Monzen S et al. Relationship between radiosensitivity and Nrf2 target gene expression in human hematopoietic stem cells. Radiat Res 2010;174:177-84.